Americans will start receiving Johnson & Johnson‘s COVID-19 vaccine within the next 24 to 48 hours, J&J CEO Alex Gorsky told NBC’s Today this morning.
FDA issued an EUA for J&J’s Ad26.COV2-S vaccine on Feb. 27, a day after an advisory panel unanimously recommended that the agency authorize the vaccine for adults 18 and over. J&J’s vaccine is the third COVID-19 vaccine to receive authorization in the U.S. so far.
“Literally it’s on trucks as we’re talking,” Gorsky told Today. There are 4 million doses being shipped at this time, with plans to ship a total 20 million by the end of March and 100 million by the end of June.
Get the full story at our sister site, Drug Discovery & Development.
This article originally ran on Feb. 26, 2021. Updated Feb. 27 with news of the FDA emergency use authorization — and March 1 with J&J CEO Alex Gorsky discussing vaccine distribution.